A 52 year old white male with chronic psoriasis first diagnosed Aspril 1992 was placed on 12.5 mg/week methotrexate and oral immunisuppressant medication October 1997. After commencing the medication, the condition reduced from 6% body coverage with flares of 15-20% to a body coverage of 5%. After approx. 6 weeks of Network Spinal Analysis (NSA) patient was taken off oral medication. For 5 months since cessation of methotrexate, the patient remained under NSA with no recurrence of psoriasis body coverage greater than 1%.
Madeline Behrendt, D.C. Journal of Vertebral Subluxation Research ~ Volume 2 ~ Number 4 ~ Pages 1-5. Abstract